Xiaofang Zhao
Overview
Explore the profile of Xiaofang Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
1552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu J, Zhao X, Ren B, Duan X, Sun J
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076465
Hepatocellular carcinoma (HCC) is a malignant tumor with high morbidity and mortality. Radiotherapy technology is a common treatment modality that can be used in all stages of HCC. However, in...
2.
Sun Y, Zhao X, Wang M, Sun X, Mei K, Zhang Y, et al.
BMC Oral Health
. 2025 Jan;
25(1):112.
PMID: 39838371
Background: Lip behaviors can lead to maxillofacial developmental disorders such as anterior open bite, posterior crossbite, increased overjet, and a higher risk of developing a Class II malocclusion. However, lip-sucking,...
3.
Zhao X, Wang S, Liu Q, Wei W, Sun X, Song H, et al.
Clin Transl Med
. 2025 Jan;
15(1):e70198.
PMID: 39834100
Alcohol-related liver disease (ALD) is a common chronic liver disease caused by long-term excessive alcohol consumption and responsible for more than half of all liver-related deaths worldwide. The molecular mechanisms...
4.
Qin C, Zhao X, Wang S, Shen Y
J Chem Phys
. 2025 Jan;
161(24.
PMID: 39786909
The collisional energy transfer between vibrational excited H2(1, 7) and CO2 was investigated by exciting H2 to a vibrational excited state of v = 1, J = 7 by the...
5.
Wang X, Wu J, Ye H, Zhao X, Zhu S
CPT Pharmacometrics Syst Pharmacol
. 2025 Jan;
PMID: 39778004
Rheumatoid arthritis (RA) is a major public health concern, which can cause serious outcomes. Low-dose methotrexate (MTX) is a cornerstone in RA treatment, but there is significant heterogeneity in clinical...
6.
Wu J, Wang X, Zhao X, Zhu S
Expert Opin Drug Saf
. 2024 Dec;
:1-9.
PMID: 39709527
Background: Recent clinical case reports have generated controversy concerning the adverse events (AEs) of amputation linked to sodium-glucose co-transporter 2 inhibitors (SGLT2i). We assessed the risk of osteomyelitis AE reporting...
7.
Sun J, Li W, He W, Yang Y, Duan L, Su T, et al.
J Hepatocell Carcinoma
. 2024 Nov;
11:2199-2210.
PMID: 39558967
Purpose: Radiofrequency ablation (RFA) is a micro-invasive treatment for early-stage HCC patients. Stereotactic body radiation therapy (SBRT) has also been proven an effective and safe treatment for HCC patients. This...
8.
Wang S, Liu Q, Sun X, Wei W, Ding L, Zhao X
Sci Rep
. 2024 Nov;
14(1):27381.
PMID: 39521930
Progressive familial intrahepatic cholestasis type 3 (PFIC3) is a severe hepatic disorder characterized by cholestasis. Elucidating the genotype-phenotype correlations and expanding the mutational spectrum of the ABCB4 gene are crucial...
9.
Zheng H, Guo T, Zhao X, Wang K, Shan S, Xie S, et al.
Dig Dis
. 2024 Nov;
43(1):75-83.
PMID: 39496224
Introduction: Previous studies reported inconsistent results of the association between Helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD). Methods: A cohort study of 2,063 adults without NAFLD at baseline,...
10.
Sun X, Zhao X, Wang S, Liu Q, Wei W, Xu J, et al.
Front Immunol
. 2024 Oct;
15:1477267.
PMID: 39399493
Background And Aim: Cholangiocarcinoma (CCA) is a rare cancer, yet its incidence and mortality rates have been steadily increasing globally over the past few decades. Currently, there are no effective...